Meeting of the Tick-Borne Disease Working Group, 3314 [2022-01106]
Download as PDF
3314
Federal Register / Vol. 87, No. 14 / Friday, January 21, 2022 / Notices
TOTAL ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Form
Total
responses
Burden hours
per response
Total burden
hours
Grant Report ........................................................................
700
1
700
36
25,200
Total ..............................................................................
700
........................
700
........................
25,200
HRSA specifically requests comments
on (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2022–01114 Filed 1–20–22; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Tick-Borne Disease
Working Group
Office of the Assistant
Secretary for Health, Office of the
Secretary, Department of Health and
Human Services.
AGENCY:
ACTION:
Notice.
As required by the Federal
Advisory Committee Act, the
Department of Health and Human
Services (HHS) is hereby giving notice
that the Tick-Borne Disease Working
Group (TBDWG) will hold a virtual
meeting. The meeting will be open to
the public. For this meeting, the
TBDWG will (1) hear presentations from
six subcommittees on findings and
potential actions from reports prepared
for the TBDWG to consider and (2)
further discuss plans for developing the
next report to the HHS Secretary and
Congress on federal tick-borne activities
and research, taking into consideration
the 2018 and 2020 report. The 2022
report will address a wide range of
topics related to tick-borne diseases,
such as, surveillance, prevention,
diagnosis, diagnostics, and treatment;
identify advances made in research, as
well as overlap and gaps in tick-borne
disease research; and provide
recommendations regarding any
appropriate changes or improvements to
such activities and research.
SUMMARY:
jspears on DSK121TN23PROD with NOTICES1
Responses
per
respondent
VerDate Sep<11>2014
17:39 Jan 20, 2022
Jkt 256001
The meeting will be held online
via webcast on February 28–March 1,
2022 from approximately 9:00 a.m. to
5:00 p.m. ET (times are tentative and
subject to change) each day. The
confirmed times and agenda items for
the meeting will be posted on the
TBDWG web page at https://
www.hhs.gov/ash/advisory-committees/
tickbornedisease/meetings/2022-02-28/
index.html when this information
becomes available.
FOR FURTHER INFORMATION CONTACT:
James Berger, Designated Federal Officer
for the TBDWG; Office of Infectious
Disease and HIV/AIDS Policy, Office of
the Assistant Secretary for Health,
Department of Health and Human
Services, Mary E. Switzer Building, 330
C Street SW, Suite L600, Washington,
DC 20024. Email: tickbornedisease@
hhs.gov. Phone: 202–795–7608.
SUPPLEMENTARY INFORMATION:
Registration information can be found
on the meeting website at https://
www.hhs.gov/ash/advisory-committees/
tickbornedisease/meetings/2022-02-28/
index.html when it becomes available.
The public will have an opportunity to
present their views to the TBDWG orally
during the meeting’s public comment
session or by submitting a written
public comment. Comments should be
pertinent to the meeting discussion.
Persons who wish to provide verbal or
written public comment should review
instructions at https://www.hhs.gov/
ash/advisory-committees/
tickbornedisease/meetings/2022-02-28/
index.html and respond by midnight
February 16, 2022 ET. Verbal comments
will be limited to three minutes each to
accommodate as many speakers as
possible during the 30 minute session.
Written public comments will be
accessible to the public on the TBDWG
web page prior to the meeting.
Background and Authority: The TickBorne Disease Working Group was
established on August 10, 2017, in
accordance with Section 2062 of the
21st Century Cures Act, and the Federal
Advisory Committee Act, 5 U.S.C. App.,
as amended, to provide expertise and
review federal efforts related to all tickborne diseases, to help ensure
interagency coordination and minimize
overlap, and to examine research
DATES:
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
priorities. The TBDWG is required to
submit a report to the HHS Secretary
and Congress on their findings and any
recommendations for the federal
response to tick-borne disease every two
years.
Dated: January 10, 2022.
James J. Berger,
Designated Federal Officer, Tick-Borne
Disease Working Group, Office of Infectious
Disease and HIV/AIDS Policy.
[FR Doc. 2022–01106 Filed 1–20–22; 8:45 am]
BILLING CODE 4150–28–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Advisory Committee on
Children and Disasters
Office of the Assistant
Secretary for Preparedness and
Response (ASPR), Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
The National Advisory
Committee on Children and Disasters
(NACCD or the Committee) is required
by section 2811A of the PHS Act as
amended by the Pandemic and All
Hazards Preparedness and Advancing
Innovation Act (PAHPAIA) and
governed by the provisions of the
Federal Advisory Committee Act
(FACA). The NACCD shall evaluate
issues and programs and provide
findings, advice, and recommendations
to the Secretary of HHS to support and
enhance all-hazards public health and
medical preparedness, response, and
recovery aimed at meeting the unique
needs of children and their families
across the entire spectrum of their
wellbeing. The Secretary of HHS has
formally delegated authority to operate
the NACCD to ASPR.
DATES: The NACCD will conduct an
inaugural public meeting (virtual) on
February 17, 2022. The new advisory
committee will be sworn in along with
the presentation and discussion of
challenges, opportunities, and priorities
for national public health and medical
preparedness, response and recovery,
specific to the needs of children and
their families in disasters. A more
SUMMARY:
E:\FR\FM\21JAN1.SGM
21JAN1
Agencies
[Federal Register Volume 87, Number 14 (Friday, January 21, 2022)]
[Notices]
[Page 3314]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-01106]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meeting of the Tick-Borne Disease Working Group
AGENCY: Office of the Assistant Secretary for Health, Office of the
Secretary, Department of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: As required by the Federal Advisory Committee Act, the
Department of Health and Human Services (HHS) is hereby giving notice
that the Tick-Borne Disease Working Group (TBDWG) will hold a virtual
meeting. The meeting will be open to the public. For this meeting, the
TBDWG will (1) hear presentations from six subcommittees on findings
and potential actions from reports prepared for the TBDWG to consider
and (2) further discuss plans for developing the next report to the HHS
Secretary and Congress on federal tick-borne activities and research,
taking into consideration the 2018 and 2020 report. The 2022 report
will address a wide range of topics related to tick-borne diseases,
such as, surveillance, prevention, diagnosis, diagnostics, and
treatment; identify advances made in research, as well as overlap and
gaps in tick-borne disease research; and provide recommendations
regarding any appropriate changes or improvements to such activities
and research.
DATES: The meeting will be held online via webcast on February 28-March
1, 2022 from approximately 9:00 a.m. to 5:00 p.m. ET (times are
tentative and subject to change) each day. The confirmed times and
agenda items for the meeting will be posted on the TBDWG web page at
https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/2022-02-28/ when this information becomes available.
FOR FURTHER INFORMATION CONTACT: James Berger, Designated Federal
Officer for the TBDWG; Office of Infectious Disease and HIV/AIDS
Policy, Office of the Assistant Secretary for Health, Department of
Health and Human Services, Mary E. Switzer Building, 330 C Street SW,
Suite L600, Washington, DC 20024. Email: [email protected].
Phone: 202-795-7608.
SUPPLEMENTARY INFORMATION: Registration information can be found on the
meeting website at https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/2022-02-28/ when it becomes
available. The public will have an opportunity to present their views
to the TBDWG orally during the meeting's public comment session or by
submitting a written public comment. Comments should be pertinent to
the meeting discussion. Persons who wish to provide verbal or written
public comment should review instructions at https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/2022-02-28/ and
respond by midnight February 16, 2022 ET. Verbal comments will be
limited to three minutes each to accommodate as many speakers as
possible during the 30 minute session. Written public comments will be
accessible to the public on the TBDWG web page prior to the meeting.
Background and Authority: The Tick-Borne Disease Working Group was
established on August 10, 2017, in accordance with Section 2062 of the
21st Century Cures Act, and the Federal Advisory Committee Act, 5
U.S.C. App., as amended, to provide expertise and review federal
efforts related to all tick-borne diseases, to help ensure interagency
coordination and minimize overlap, and to examine research priorities.
The TBDWG is required to submit a report to the HHS Secretary and
Congress on their findings and any recommendations for the federal
response to tick-borne disease every two years.
Dated: January 10, 2022.
James J. Berger,
Designated Federal Officer, Tick-Borne Disease Working Group, Office of
Infectious Disease and HIV/AIDS Policy.
[FR Doc. 2022-01106 Filed 1-20-22; 8:45 am]
BILLING CODE 4150-28-P